Simplex Trading’s Instil Bio TIL Stock Holding History

Simplex Trading’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20	Closed	-$1K	–	10435
2022 Q3	$1K	Buy	+20	New	+$2.29K	﹤0.01%	9650

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Simplex Trading's TIL Position: Q4 2023 in Review

Simplex Trading sold out of Instil Bio (TIL) in Q4 2023, closing a stake of 746 shares — an estimated $6K sold.

Simplex Trading first reported a position in TIL in Q3 2022 and held it in 5 quarters. The position peaked at $22K in Q2 2023. 30 funds tracked by Wall St. Rank hold TIL as of Q4 2023.

Simplex Trading reported no remaining Instil Bio position as of Q4 2023 after selling out during the quarter.
Simplex Trading sold 746 Instil Bio shares in Q4 2023, an estimated $6K.
Simplex Trading first reported a position in Instil Bio in Q3 2022 and held it in 5 quarters.
Simplex Trading's Instil Bio position peaked at $22K in Q2 2023.
30 funds tracked by Wall St. Rank held Instil Bio as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.